STOCK TITAN

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings

Zomedica (NYSE American:ZOM) has scheduled its Fourth Quarter and Full Year 2024 Financial Results conference call and audio webcast for March 13, 2025, at 4:30 p.m. ET. The veterinary health company, which specializes in point-of-care diagnostic and therapeutic products for equine and companion animals, will present operational and financial highlights followed by a Q&A session.

Interested participants can join via phone at +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International). A replay will be available until March 27, 2025, at 11:59 PM ET by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) with pin number: 1174148.

Zomedica (NYSE American:ZOM) ha programmato la sua chiamata di conferenza e webcast audio sui risultati finanziari del Quarto Trimestre e dell'Anno Completo 2024 per il 13 marzo 2025, alle 16:30 ET. L'azienda di salute veterinaria, specializzata in prodotti diagnostici e terapeutici per animali equini e da compagnia, presenterà i momenti salienti operativi e finanziari seguiti da una sessione di domande e risposte.

I partecipanti interessati possono unirsi telefonicamente al numero +1-800-717-1738 (numero verde USA) o +1-646-307-1865 (internazionale). Una registrazione sarà disponibile fino al 27 marzo 2025, alle 23:59 ET, componendo +1-844-512-2921 (numero verde USA) o +1-412-317-6671 (internazionale) con il numero PIN: 1174148.

Zomedica (NYSE American:ZOM) ha programado su llamada de conferencia y webcast de audio sobre los resultados financieros del Cuarto Trimestre y del Año Completo 2024 para el 13 de marzo de 2025, a las 4:30 p.m. ET. La empresa de salud veterinaria, que se especializa en productos diagnósticos y terapéuticos para animales equinos y de compañía, presentará los aspectos destacados operativos y financieros, seguido de una sesión de preguntas y respuestas.

Los participantes interesados pueden unirse por teléfono al +1-800-717-1738 (número gratuito en EE. UU.) o +1-646-307-1865 (internacional). Una repetición estará disponible hasta el 27 de marzo de 2025, a las 11:59 p.m. ET, marcando el +1-844-512-2921 (número gratuito en EE. UU.) o +1-412-317-6671 (internacional) con el número PIN: 1174148.

조메디카 (NYSE American:ZOM)는 2024년 4분기 및 전체 연도 재무 결과에 대한 컨퍼런스 콜 및 오디오 웹캐스트를 2025년 3월 13일 오후 4시 30분 ET에 예정하고 있습니다. 동물 진료에 특화된 이 수의학 회사는 말과 반려동물용 진단 및 치료 제품을 전문으로 하며, 운영 및 재무 하이라이트를 발표한 후 질의응답 세션을 진행할 예정입니다.

관심 있는 참가자는 +1-800-717-1738 (미국 무료전화) 또는 +1-646-307-1865 (국제전화)로 전화로 참여할 수 있습니다. 재생은 2025년 3월 27일 오후 11시 59분 ET까지 +1-844-512-2921 (미국 무료전화) 또는 +1-412-317-6671 (국제전화)로 전화하여 PIN 번호: 1174148로 이용할 수 있습니다.

Zomedica (NYSE American:ZOM) a programmé sa conférence téléphonique et son webinaire audio sur les résultats financiers du quatrième trimestre et de l'année 2024 pour le 13 mars 2025 à 16h30 ET. L'entreprise de santé vétérinaire, spécialisée dans les produits diagnostiques et thérapeutiques pour les animaux équins et de compagnie, présentera les points saillants opérationnels et financiers, suivis d'une session de questions-réponses.

Les participants intéressés peuvent se joindre par téléphone au +1-800-717-1738 (numéro gratuit aux États-Unis) ou +1-646-307-1865 (international). Un enregistrement sera disponible jusqu'au 27 mars 2025 à 23h59 ET en composant le +1-844-512-2921 (numéro gratuit aux États-Unis) ou +1-412-317-6671 (international) avec le numéro PIN : 1174148.

Zomedica (NYSE American:ZOM) hat seine Konferenzschaltung und Audio-Webcast zu den finanziellen Ergebnissen des vierten Quartals und des gesamten Jahres 2024 für den 13. März 2025 um 16:30 Uhr ET angesetzt. Das Unternehmen für veterinärmedizinische Gesundheit, das sich auf diagnostische und therapeutische Produkte für Pferde und Haustiere spezialisiert hat, wird betriebliche und finanzielle Highlights präsentieren, gefolgt von einer Frage-und-Antwort-Runde.

Interessierte Teilnehmer können telefonisch unter +1-800-717-1738 (US-gebührenfrei) oder +1-646-307-1865 (international) teilnehmen. Eine Wiederholung wird bis zum 27. März 2025 um 23:59 Uhr ET zur Verfügung stehen, indem sie +1-844-512-2921 (US-gebührenfrei) oder +1-412-317-6671 (international) mit der PIN-Nummer: 1174148 anrufen.

Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, March 13, 2025, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and full year ended December 31, 2024. A question-and-answer session will follow management's prepared remarks.

Event: Zomedica Corp. Q4 and FY 2024 Financial Results Conference Call

Date: Thursday, March 13, 2025

Time: 4:30 p.m. Eastern Time

Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)

Webcast: LINK

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, March 27, 2025 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1174148

About Zomedica

Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW™ digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. An NYSE American company, Zomedica grew revenue 33% in 2023 to $25 million and maintains a strong balance sheet with approximately $78 million in liquidity as of September 30, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit www.zomedica.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
X (formerly Twitter): https://x.com/zomedica
Facebook: https://m.facebook.com/zomedica
Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on ACCESS Newswire

FAQ

When will Zomedica (ZOM) release its Q4 and FY 2024 earnings?

Zomedica will release its Q4 and FY 2024 earnings on March 13, 2025, at 4:30 p.m. ET.

How can investors join Zomedica's (ZOM) Q4 2024 earnings call?

Investors can join via phone at +1-800-717-1738 (U.S.) or +1-646-307-1865 (International), or through the webcast.

Until when is the replay of ZOM's Q4 2024 earnings call available?

The earnings call replay will be available until March 27, 2025, at 11:59 PM ET.

What is the replay pin number for Zomedica's (ZOM) Q4 2024 earnings call?

The replay pin number is 1174148.

Zomedica Corp

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

102.50M
961.51M
1.78%
8.33%
5.12%
Medical Devices
Pharmaceutical Preparations
Link
United States
ANN ARBOR